BioCentury
ARTICLE | Financial News

Caxton Advantage Venture Partners financial update

February 27, 2012 8:00 AM UTC

The life sciences team of Caxton Advantage will form Valence Life Sciences, an independent investment firm focused on private and micro-cap public clinical-stage life science companies. The team will ...